Teachers\u27, Students\u27, and Principal\u27s Perceptions of School Effectiveness Factors at Sullivan High School

Statement of Purpose The purpose of this field experience is to compare and contrast school effectiveness factors from the prospectives of students, teachers, and principal (the researcher) of Sullivan High School. In order to evaluate the effectiveness of a school, the perceptions of these people are determined to be most important. Therefore, this researcher recognized the need to ascertain and study such data. Procedure Three surveys were developed by Dr. Dave Bartz, Associate Professor of Educational Administration of Eastern Illinois University, based on a review of current literature addressing the issue of identifying school effectiveness factors. These were a Teacher Feedback Survey, Student Feedback Survey, and Principal Feedback Survey. The surveys were distributed to the teachers and students on February 7, 1985. The surveys were scored by the computer center at Eastern Illinois University. The study is divided into five chapters. Chapter One gives background information concerning why this topic was chosen, relates the specific statement of the problem being researched, and gives the limitations of the study. Chapter Two is a study of the related literature and research concerning school effectiveness factors. Chapter Three expains the design of the study, the method of data collection and instrumentation, and the method of data analysis. Chapter Four lists the results, recommendations, and conclusions of the data that was collected from the three surveys. Chapter Five summarizes the recommendations of the researcher based on the results of the surveys. Twenty recommendations are listed

A Large-Scale FPGA-Based Trigger and Dead-Time Free DAQ System for the Kaos Spectrometer at MAMI

The Kaos spectrometer is maintained by the A1 collaboration at the Mainz Microtron MAMI with a focus on the study of (e,e'K^+) coincidence reactions. For its electron-arm two vertical planes of fiber arrays, each comprising approximately 10 000 fibers, are operated close to zero degree scattering angle and in close proximity to the electron beam. A nearly dead-time free DAQ system to acquire timing and tracking information has been installed for this spectrometer arm. The signals of 144 multi-anode photomultipliers are collected by 96-channel front-end boards, digitized by double-threshold discriminators and the signal time is picked up by state-of-the-art F1 time-to-digital converter chips. In order to minimize background rates a sophisticated trigger logic was implemented in newly developed Vuprom modules. The trigger performs noise suppression, signal cluster finding, particle tracking, and coincidence timing, and can be expanded for kinematical matching (e'K^+) coincidences. The full system was designed to process more than 4 000 read-out channels and to cope with the high electron flux in the spectrometer and the high count rate requirement of the detectors. It was successfully in-beam tested at MAMI in 2009.Comment: Contributed to 17th IEEE Real Time Conference (RT10), Lisbon, 24-28 May 201

A measurable entanglement criterion for two qubits

We propose a directly measurable criterion for the entanglement of two qubits. We compare the criterion with other criteria, and we find that for pure states, and some mixed states, it coincides with the state's concurrency. The measure can be obtained with a Bell state analyser and the ability to make general local unitary transformations. However, the procedure fails to measure the entanglement of a general mixed two-qubit state.Comment: 5 page

Current collaboration between palliative care and neurology: a survey of clinicians in Europe

Introduction: The collaboration between palliative care and neurology has developed over the last 25 years and this study aimed to ascertain the collaboration between the specialties across Europe. Methods: This online survey aimed to look at collaboration across Europe, using the links of the European Association for Palliative Care and the European Academy of Neurology. Results: 298 people completed the survey—178 from palliative care and 120 from neurology from over 20 countries across Europe. They reported that there was good collaboration in the care for people with amyotrophic lateral sclerosis and cerebral tumours but less for other progressive neurological diseases. The collaboration included joint meetings and clinics and telephone contacts. All felt that the collaboration was helpful, particularly for maintaining quality of life, physical symptom management, psychological support and complex decision making, including ethical issues. Discussion: The study shows evidence for collaboration between palliative care and neurology, but with the need to develop this for all neurological illness, and there is a need for increased education of both areas

Symptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factors

BACKGROUND Palliative care is increasingly offered earlier in the cancer trajectory but rarely in Idiopathic Parkinson's Disease(IPD), Progressive Supranuclear Palsy(PSP) or Multiple System Atrophy(MSA). There is little longitudinal data of people with late stage disease to understand levels of need. We aimed to determine how symptoms and quality of life of these patients change over time; and what demographic and clinical factors predicted changes. METHODS We recruited 82 patients into a longitudinal study, consenting patients with a diagnosis of IPD, MSA or PSP, stages 3-5 Hoehn and Yahr(H&Y). At baseline and then on up to 3 occasions over one year, we collected self-reported demographic, clinical, symptom, palliative and quality of life data, using Parkinson's specific and generic validated scales, including the Palliative care Outcome Scale (POS). We tested for predictors using multivariable analysis, adjusting for confounders. FINDINGS Over two thirds of patients had severe disability, over one third being wheelchair-bound/bedridden. Symptoms were highly prevalent in all conditions - mean (SD) of 10.6(4.0) symptoms. More than 50% of the MSA and PSP patients died over the year. Over the year, half of the patients showed either an upward (worsening, 24/60) or fluctuant (8/60) trajectory for POS and symptoms. The strongest predictors of higher levels of symptoms at the end of follow-up were initial scores on POS (AOR 1.30; 95%CI:1.05-1.60) and being male (AOR 5.18; 95% CI 1.17 to 22.92), both were more predictive than initial H&Y scores. INTERPRETATION The findings point to profound and complex mix of non-motor and motor symptoms in patients with late stage IPD, MSA and PSP. Symptoms are not resolved and half of the patients deteriorate. Palliative problems are predictive of future symptoms, suggesting that an early palliative assessment might help screen for those in need of earlier intervention

Overexpression of Cytochrome P450 Epoxygenases Prevents Development of Hypertension in Spontaneously Hypertensive Rats by Enhancing Atrial Natriuretic Peptide

Cytochrome P450 (P450)-derived epoxyeicosatrienoic acids (EETs) exert well recognized vasodilatory, diuretic, and tubular fluid-electrolyte transport actions that are predictive of a hypotensive effect. The study sought to determine the improvement of hypertension and cardiac function by overexpressing P450 epoxygenases in vivo. Long-term expression of CYP102 F87V or CYP2J2 in spontaneously hypertensive rats (SHR) was mediated by using a type 8 recombinant adeno-associated virus (rAAV8) vector. Hemodynamics was measured by a Millar Instruments, Inc. (Houston, TX) microtransducer catheter, and atrial natriuretic peptide (ANP) mRNA levels were tested by real-time polymerase chain reaction. Results showed that urinary excretion of 14,15-EET was increased at 2 and 6 months after injection with rAAV-CYP102 F87V and rAAV-CYP2J2 compared with controls (p < 0.05). During the course of the 6-month study, systolic blood pressure significantly decreased in P450 epoxygenase-treated rats, but the CYP2J2-specific inhibitor C26 blocked rAAV-CYP2J2-induced hypotension and the increase in EET production. Cardiac output was improved by P450 epoxygenase expression at 6 months (p < 0.05). Furthermore, cardiac collagen content was reduced in P450 epoxygenase-treated rats. ANP mRNA levels were up-regulated 6- to 14-fold in the myocardium, and ANP expression was significantly increased in both myocardium and plasma in P450 epoxygenase-treated rats. However, epidermal growth factor (EGF) receptor antagonist 4-(3′-chloroanilino)-6,7-dimethoxy-quinazoline (AG-1478) significantly attenuated the increase in the EET-induced expression of ANP in vitro. These data indicate that overexpression of P450 epoxygenases attenuates the development of hypertension and improves cardiac function in SHR, and that these effects may be mediated, at least in part, by ANP via activating EGF receptor